Viedoc
Private Company
Total funding raised: $15M
Overview
Viedoc is a privately-held, revenue-generating provider of a modular, cloud-based eClinical platform for clinical trial management, founded in 2003 and headquartered in Uppsala, Sweden. Its core value proposition centers on predictable study-based pricing, rapid deployment, user-friendly design, and a strong compliance track record, including a 100% FDA inspection pass rate. The company has supported over 7,000 studies across 75+ countries, positioning it as a trusted, scalable solution for organizations seeking to reduce trial complexity and cost.
Technology Platform
A modular, cloud-based eClinical software suite for clinical trials, featuring a low-code Electronic Data Capture (EDC) system, electronic Patient-Reported Outcomes (ePRO), and Televisits modules. The platform emphasizes rapid deployment, real-time data validation, user-friendliness, and built-in regulatory compliance (21 CFR Part 11, GDPR, ISO 27001).
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Viedoc competes in the crowded eClinical software market against large incumbents like Medidata (a Dassault Systèmes company), Veeva Systems, and Oracle, as well as other independent players like Castor, Clinion, and BioClinica. Its primary competitive differentiators are its user-friendly, low-code design; transparent, study-based pricing (no per-seat fees); and strong track record for regulatory inspection readiness.